Literature DB >> 1877889

Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.

F Taguchi1, Y Tamai, K Uchida, R Kitajima, H Kojima, T Kawaguchi, Y Ohtani, S Miura.   

Abstract

We have examined complete inactivation conditions on brain homogenates from mice affected with Creutzfeldt-Jakob disease agent, and recommend for routine use a reliable procedure first treating the affected materials with 1 N NaOH for 60 min and then autoclaving at 121 degrees C for 30 min.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1877889     DOI： 10.1007/bf01310679

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  9 in total

1.  Unconventional viruses and the origin and disappearance of kuru.

Authors:  D C Gajdusek
Journal:  Science       Date:  1977-09-02       Impact factor: 47.728

2.  Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue.

Authors:  P Brown; R G Rohwer; D C Gajdusek
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

3.  Decontamination of Creutzfeldt-Jakob disease agent.

Authors:  D M Taylor
Journal:  Ann Neurol       Date:  1986-12       Impact factor: 10.422

4.  Inactivation of the Creutzfeldt-Jakob disease agent.

Authors:  Y Tamai; F Taguchi; S Miura
Journal:  Ann Neurol       Date:  1988-09       Impact factor: 10.422

5.  Inactivation of the Creutzfeldt-Jakob disease agent.

Authors:  J Tateishi; T Tashima; T Kitamoto
Journal:  Ann Neurol       Date:  1988-09       Impact factor: 10.422

6.  Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Committee on Health Care Issues, American Neurological Association.

Authors: 
Journal:  Ann Neurol       Date:  1986-01       Impact factor: 10.422

7.  Autoclaving standards for Creutzfeldt-Jakob disease agent.

Authors:  D M Taylor
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

8.  Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus.

Authors:  P Brown; R G Rohwer; D C Gajdusek
Journal:  N Engl J Med       Date:  1984-03-15       Impact factor: 91.245

9.  Disinfection studies with two strains of mouse-passaged scrapie agent. Guidelines for Creutzfeldt-Jakob and related agents.

Authors:  R H Kimberlin; C A Walker; G C Millson; D M Taylor; P A Robertson; A H Tomlinson; A G Dickinson
Journal:  J Neurol Sci       Date:  1983-06       Impact factor: 3.181
  9 in total
  9 in total

Review 1.  A review of materials currently used in orbital floor reconstruction.

Authors:  David Mok; Lucie Lessard; Carlos Cordoba; Patrick G Harris; Andreas Nikolis
Journal:  Can J Plast Surg       Date:  2004

2.  Experiments on maternal and paternal transmission of Creutzfeldt-Jakob disease in mice.

Authors:  F Taguchi; Y Tamai; S Miura
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Public health issues and clinical and neurological characteristics of the new variant of Creutzfeldt-Jakob disease and other human and animal transmissible spongiform encephalopathies: memorandum from two WHO meetings.

Authors: 
Journal:  Bull World Health Organ       Date:  1996       Impact factor: 9.408

4.  Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?

Authors:  Atsushi Kobayashi; Piero Parchi; Masahito Yamada; Paul Brown; Daniela Saverioni; Yuichi Matsuura; Atsuko Takeuchi; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

5.  Decontamination studies with the agents of bovine spongiform encephalopathy and scrapie.

Authors:  D M Taylor; H Fraser; I McConnell; D A Brown; K L Brown; K A Lamza; G R Smith
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Rapid and Quantitative Assay of Amyloid-Seeding Activity in Human Brains Affected with Prion Diseases.

Authors:  Hanae Takatsuki; Katsuya Satoh; Kazunori Sano; Takayuki Fuse; Takehiro Nakagaki; Tsuyoshi Mori; Daisuke Ishibashi; Ban Mihara; Masaki Takao; Yasushi Iwasaki; Mari Yoshida; Ryuichiro Atarashi; Noriyuki Nishida
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

Review 7.  Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems.

Authors:  Atsushi Kobayashi; Yuichi Matsuura; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  Acta Neuropathol Commun       Date:  2014-03-31       Impact factor: 7.801

8.  Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation.

Authors:  Kurt Giles; David V Glidden; Robyn Beckwith; Rose Seoanes; David Peretz; Stephen J DeArmond; Stanley B Prusiner
Journal:  PLoS Pathog       Date:  2008-11-14       Impact factor: 6.823

Review 9.  Prions and related neurological diseases.

Authors:  M Pocchiari
Journal:  Mol Aspects Med       Date:  1994
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.